Welcome, how can we help?
Policy Types
Getting Technical
Home / - Terminal Illness Cover
This benefit is included almost without exception free of charge on all life insurance and life assurance and/or critical illness policies.
Terminal Illness Cover pays out the sum assured immediately (instead of on death or critical illness) if the life assured is diagnosed as being terminally ill, with a life expectancy of less than 12 months typically.
This cover does not usually apply during the last 12 to 18 months of the period of cover.
NEWS
Prudential concentrates on core life insurance business
07 June 2007 16:35:02
Leading life insurance firm Prudential has announced that it intends to close its stock research and trading arm, Prudential Equity Group.
The business had traded on Wall Street for some 26 years, but without a great deal of success - while Prudential Financial managed $630 billion worth of assets, Prudential Equity held just $137 million.
Theresa Miller, a spokeswoman for Prudential Equity Group, explained the decision:
"It's a matter of scale. Prudential's strategy is to be in businesses where we have significant scale."
She continued: "The research and trading markets are really competitive, really challenging and are not an area where we've been able to achieve that scale or success for our clients, for our shareholders and certainly our employees."
Around 420 jobs will be lost following the move, affecting employees in nine US cities, as well as in London, Zurich, Paris and Tokyo.
Prudential recently announced that it will take a 39 per cent stake in a Saudi Arabian life insurance venture.
New study shows improved cancer predictions
31 January 2008 17:43:22
Medical techniques using biomarker assessments have made new progress in predicting people's susceptibility to cancer, it has emerged.
The likelihood of prostate cancer virulence in patients has been assessed under a new model using an individual's Gleason score and biomarker assessment data.
Published online in the BMC Medical Genomics journal, researchers at the University of Texas, US, were able to detect "significant differences" in the molecular signatures linked to varying grades of tumours linked to prostate cancer.
The biomarker data included cell cycle and cell death regulators that are known to be expressed during stages of the disease.
Valuable information regarding the risk of disease progression has been discovered, said Dr Timothy McDonnell, lead researcher at the university.
"With this type of information patients could be more appropriately managed based on their individual risk profile," he added.
National prostate cancer awareness week 2008 takes place between March 10th and 16th, organised by the prostate cancer charity.
Re-check your life insurance details
03 July 2007 11:54:49
Leading UK life cover firm Norwich Union is to ask 5,000 of its customers to run a fine toothcomb over their policy applications, in order to reduce the number of rejected claims, reports the Times.
Around one in five claims are rejected annually, due to non-disclosure, with many British consumers unsure of the level of detail needed when applying for UK life insurance.
Some 5,000 of Norwich Union's two million customers have been selected for the insurer's trial system and will be sent a letter over the next three months asking them to check their policies for vital omissions.
Explaining the decision to the newspaper, Willie Mowatt, direct of risk products at Norwich Union, said:
"We want to be able to clearly advise people who think they may have non-disclosed how to proceed if they believe they may have missed something off their application form."
Any policyholders not included in the trial system can contact Norwich Union to check their application if they are concerned that they might have unwittingly neglected to disclose important information.
The insurance group's decision has almost certainly been inspired by the April 2007 publication of new critical illness definitions by the Association of British Insurers, which aimed to reduce the number of rejected claims.
07 June 2007 16:35:02
Leading life insurance firm Prudential has announced that it intends to close its stock research and trading arm, Prudential Equity Group.
The business had traded on Wall Street for some 26 years, but without a great deal of success - while Prudential Financial managed $630 billion worth of assets, Prudential Equity held just $137 million.
Theresa Miller, a spokeswoman for Prudential Equity Group, explained the decision:
"It's a matter of scale. Prudential's strategy is to be in businesses where we have significant scale."
She continued: "The research and trading markets are really competitive, really challenging and are not an area where we've been able to achieve that scale or success for our clients, for our shareholders and certainly our employees."
Around 420 jobs will be lost following the move, affecting employees in nine US cities, as well as in London, Zurich, Paris and Tokyo.
Prudential recently announced that it will take a 39 per cent stake in a Saudi Arabian life insurance venture.
31 January 2008 17:43:22
Medical techniques using biomarker assessments have made new progress in predicting people's susceptibility to cancer, it has emerged.
The likelihood of prostate cancer virulence in patients has been assessed under a new model using an individual's Gleason score and biomarker assessment data.
Published online in the BMC Medical Genomics journal, researchers at the University of Texas, US, were able to detect "significant differences" in the molecular signatures linked to varying grades of tumours linked to prostate cancer.
The biomarker data included cell cycle and cell death regulators that are known to be expressed during stages of the disease.
Valuable information regarding the risk of disease progression has been discovered, said Dr Timothy McDonnell, lead researcher at the university.
"With this type of information patients could be more appropriately managed based on their individual risk profile," he added.
National prostate cancer awareness week 2008 takes place between March 10th and 16th, organised by the prostate cancer charity.
03 July 2007 11:54:49
Leading UK life cover firm Norwich Union is to ask 5,000 of its customers to run a fine toothcomb over their policy applications, in order to reduce the number of rejected claims, reports the Times.
Around one in five claims are rejected annually, due to non-disclosure, with many British consumers unsure of the level of detail needed when applying for UK life insurance.
Some 5,000 of Norwich Union's two million customers have been selected for the insurer's trial system and will be sent a letter over the next three months asking them to check their policies for vital omissions.
Explaining the decision to the newspaper, Willie Mowatt, direct of risk products at Norwich Union, said:
"We want to be able to clearly advise people who think they may have non-disclosed how to proceed if they believe they may have missed something off their application form."
Any policyholders not included in the trial system can contact Norwich Union to check their application if they are concerned that they might have unwittingly neglected to disclose important information.
The insurance group's decision has almost certainly been inspired by the April 2007 publication of new critical illness definitions by the Association of British Insurers, which aimed to reduce the number of rejected claims.